HCG Research Material Canada: 10,000 IU Overview
HCG 10,000 IU is supplied in Canada for laboratory research on human chorionic gonadotropin, a heterodimeric glycoprotein hormone that activates the luteinizing hormone/choriogonadotropin receptor (LHCGR). Its shared receptor with luteinizing hormone makes hCG particularly useful for studying ligand-specific receptor kinetics, cAMP signalling and endocrine response patterns. The stated IU value is a product specification and not administration guidance.
Quick Research Profile
| Material |
Human chorionic gonadotropin (hCG) |
| Strength |
10,000 IU |
| Research classification |
Heterodimeric glycoprotein hormone |
| Primary research pathways |
Luteinizing hormone/choriogonadotropin receptor (LHCGR), cAMP and endocrine signalling |
| Literature status |
Extensive receptor, reproductive-endocrine and clinical literature |
| Intended use |
Laboratory research only — not for human or veterinary use |
LHCGR Pharmacology and LH/hCG Signalling Differences
Binding of hCG to LHCGR activates G-protein-coupled signalling, prominently including cAMP pathways, with additional downstream signalling depending on cell type and experimental context. Comparative LH/hCG research investigates how two related hormones interact with the same receptor yet can generate distinct cellular responses.
Key hCG / LHCGR Research Areas
- LHCGR receptor pharmacology: hCG is a principal ligand used to investigate LHCGR binding and activation.
- Endocrine signalling: Researchers examine cAMP, ERK and steroidogenic signalling downstream of receptor activation.
- LH versus hCG comparison: Studies explore ligand-specific receptor kinetics and signalling differences.
Evidence Quality and Interpretation
hCG is extensively characterized in basic and clinical science. This page, however, concerns a research-use-only material and does not imply clinical equivalence, therapeutic approval or suitability for fertility-related use.
Research Limitations and Responsible Interpretation
IU is a biological-activity unit and should not be interpreted as a dosing recommendation. No administration, treatment or personal-use guidance is provided or implied.
Published findings describe specific experimental preparations and study conditions. They do not establish that a commercial research material is equivalent to a regulated pharmaceutical product, and they should not be interpreted as evidence of safety, efficacy or suitability for personal use.
Scientific References
References are provided for scientific context. Researchers should review the original methods, material identity, model and limitations before using published findings to inform experimental design.
Research FAQ: Human chorionic gonadotropin (hCG)
What receptor does hCG activate?
Human chorionic gonadotropin activates the luteinizing hormone/choriogonadotropin receptor, or LHCGR, a G-protein-coupled receptor involved in reproductive-endocrine signalling.
Why compare LH and hCG in receptor research?
LH and hCG share LHCGR but can produce differences in receptor kinetics and downstream signalling. That makes the pair useful for ligand-specific endocrine pharmacology research.
What does IU mean on this research listing?
IU is a biological-activity unit used to describe the product specification. It should not be interpreted as a human or veterinary dose.
Is Tier One’s HCG 10,000 IU a fertility medication?
No. This listing is for laboratory research only and is not represented as a regulated pharmaceutical, fertility treatment or personal-use product.
Canadian Research Procurement
Tier One supplies HCG 10,000 IU for qualified Canadian research procurement. Laboratories working with receptor pharmacology, neuroendocrine and endocrine-signalling models can review the Hormone & Endocrine Peptides collection for related materials. Product-specific identity, purity and analytical statements should be verified from current batch documentation. For research purposes only. Not for human or veterinary use or consumption.
